International Patent: JAK2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS

GENEVA, July 1 -- PRELUDE THERAPEUTICS INCORPORATED filed a patent application (US2025/058951) for “JAK2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS”. With publication no. WO/2026/128575, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61P 35/02

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....